Market research
KLY.V Kalytera Therapeutics, Inc
V CAD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 26M
- P/E ratio
- Not available
- Analyst target
- 0.12
- Dividend yield
- 0.0%
- Beta
- 2.92
Profile
Company facts
- Exchange
- V
- Currency
- CAD
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- CA48349P1036
- Market cap
- 26M
- P/E ratio
- Not available
- Analyst target
- 0.12
- Dividend yield
- 0.0%
- Beta
- 2.92
About
About Kalytera Therapeutics, Inc
Kalytera Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapies for patients with unmet medical needs. Kalytera Therapeutics, Inc. was founded in 2014 and is headquartered in San Rafael, California.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the KLY.V discussion.
5 years, 5 months ago
Kalytera Therapeutics, Inc is currently in a long term downtrend where the price is trading 2.7% below its 200 day moving average.
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Kalytera Therapeutics, Inc's total revenue sank by nan% to $0 since the same quarter in the previous year.
Its net income has increased by 57.7% to $-413K since the same quarter in the previous year.
Finally, its free cash flow grew by 124.0% to $267K since the same quarter in the previous year.
Based on the above factors, Kalytera Therapeutics, Inc gets an overall score of 3/5.